Operator: Good afternoon, and welcome to the Evoke Pharma, Inc. Fourth Quarter and Full Year 2024 Earnings Conference Call. Currently, all callers have been placed in a listen-only mode.

Dr. Elisabeth Potter recently went viral for a video in which she described an insurance company’s inquiry into a prior ...

Prior authorization’ hassles common, two doctors tell ‘CUOMO’ Dr. Elisabeth Potter recently went viral for a video in which ...

At the hearing, he emphasized the need to provide high-quality, compassionate care while also holding down spending.

The Missouri House has passed HB618, a bill aimed at reducing insurance red tape by easing prior authorization requirements ...

The European Travel Information and Authorization System has been pushed back to 2026. Here's what you need to know about the ETIAS "visa" ahead of a future trip to Europe.

Evoke Pharma, Inc. ( NASDAQ: EVOK) Q4 2024 Earnings Conference Call March 13, 2025 4:30 PM ET Daniel Kontoh-Boateng – DKB Partners Matt D’Onofrio – Chief Executive Officer Chris Quesenberry – Chief ...

Prior authorization may be a barrier to cost-effective care for patients undergoing primary total knee arthroplasty, according to results presented here.“All of the nonoperative and conservative ...

CMS cannot finalize policies that were not, in some way, shape, or form, included in the proposed reg. While CMS can ...

For many patients battling cancer, time can mean everything. But due to insurance rules around prior authorization, some patients run out of time. That is a problem that is being looked at in the ...

“The Board’s decision to repurchase stock was based on the strength of the Company’s balance sheet and capital position. We believe this is an appropriate way to utilize capital and enhance ...

Churchill Downs Incorporated (“CDI” or “the Company”) (Nasdaq: CHDN) announced today that the Company’s Board of Directors approved a $500 million share repurchase program. The new share repurchase ...